Since its emergence in late 2019, SARS-coronavirus 2 (SARS-CoV-2) and the resulting disease, COVID-19, have spread to over 200 countries, caused over 1M human deaths, and created tremendous economic hardship around the world. Because the virus can be transmitted asymptomatically, it is especially difficult to contain viral transmission and to track its spread… especially as the virus evolves and more highly contagious variants emerge.
Roche has joined thousands of scientists around the world in the effort to understand this disease, track its spread, identify emerging variants, and accelerate the detection of both SARS-CoV-2 and the antibodies against it.
In addition to the Roche Solutions for clinical COVID-19 testing, our workflows and reagents for next-generation sequencing (NGS) and real-time PCR-based analysis offer a powerful set of tools for COVID-19 research and surveillance of SARS-CoV-2 variants. Choose from diverse solutions based on next-generation sequencing or real-time PCR.